IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Computer-Aided Drug Design

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.73

h-Index

2022-2023

 31

Rank

2022-2023

 16573

SJR

2022-2023

 0.258

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Computer-Aided Drug Design
Abbreviation Curr. Comput.-Aided Drug Des.
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)
h-index 31
Overall Rank/Ranking 16573
SCImago Journal Rank (SJR) 0.258
Impact Score 1.73
Publisher Bentham Science Publishers B.V.
Country United Arab Emirates
ISSN 15734099
Best Quartile Q3
Coverage History 2006-2022




Aim and Scope


Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.


About Current Computer-Aided Drug Design


Current Computer-Aided Drug Design is a journal covering the technologies/fields/categories related to Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Current Computer-Aided Drug Design is 16573. According to SCImago Journal Rank (SJR), this journal is ranked 0.258. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 31. The best quartile for this journal is Q3.

The ISSN of Current Computer-Aided Drug Design journal is 15734099. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Computer-Aided Drug Design is cited by a total of 320 articles during the last 3 years (Preceding 2022).


Current Computer-Aided Drug Design Impact IF 2022-2023


The Impact IF 2022 of Current Computer-Aided Drug Design is 1.73, which is computed in 2023 as per its definition. Current Computer-Aided Drug Design IF is increased by a factor of 0.18 and approximate percentage change is 11.61% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Computer-Aided Drug Design Impact IF 2023 Prediction


Impact IF 2022 of Current Computer-Aided Drug Design is 1.73. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Current Computer-Aided Drug Design. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.73
2021 1.55
2020 1.32
2019 0.77
2018 1.03
2017 0.74
2016 0.79
2015 1.32
2014 1.21

Current Computer-Aided Drug Design h-index


  Table Setting

Current Computer-Aided Drug Design has an h-index of 31. It means 31 articles of this journal have more than 31 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Computer-Aided Drug Design ISSN


The ISSN of Current Computer-Aided Drug Design is 15734099. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Computer-Aided Drug Design Rank and SCImago Journal Rank (SJR)


The overall rank of Current Computer-Aided Drug Design is 16573. According to SCImago Journal Rank (SJR), this journal is ranked 0.258. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Computer-Aided Drug Design by Year


Year SJR
2023/2024 Coming Soon
2022 0.258
2021 0.258
2020 0.226
2019 0.216
2018 0.265
2017 0.259
2016 0.277
2015 0.322
2014 0.380

Ranking of Current Computer-Aided Drug Design by Year


Year Ranking
2023/2024 Coming Soon
2022 16573
2021 16158
2020 17810
2019 17641
2018 14938
2017 14724
2016 14250
2015 12785
2014 11033

Current Computer-Aided Drug Design Publisher


Table Setting

Current Computer-Aided Drug Design is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Computer-Aided Drug Design is Curr. Comput.-Aided Drug Des.. This abbreviation ('Curr. Comput.-Aided Drug Des.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Computer-Aided Drug Design


If your research field is/are related to Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Computer-Aided Drug Design?

Current Computer-Aided Drug Design latest impact IF is 1.73. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.73 (2022) and 0.74 (2017), respectively, in the last 9 years. Moreover, its average IS is 1.16 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design has an SJR (SCImago Journal Rank) of 0.258, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.380 in 2014 and the lowest being 0.216 in 2019. Furthermore, the average SJR of the Current Computer-Aided Drug Design over the previous 9-year period stands at 1.16.


What's the latest h-index of the Current Computer-Aided Drug Design?

The latest h-index of the Current Computer-Aided Drug Design is 31.


Who's the publisher of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.


What's the current ranking of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design is currently ranked 16573 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 11033 in 2014 and its lowest position of 17810 in 2020.


What's the abbreviation or short name for the Current Computer-Aided Drug Design?

The standard ISO4 abbreviation for the Current Computer-Aided Drug Design is Curr. Comput.-Aided Drug Des..


Is the "Current Computer-Aided Drug Design" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Computer-Aided Drug Design is classified as a journal that the Bentham Science Publishers B.V. publishes.


What's the scope or major areas of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design encompasses the following areas:

  • Drug Discovery
  • Medicine (miscellaneous)
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design is assigned the following International Standard Serial Numbers (ISSN): 15734099.


What's the best quartile of the Current Computer-Aided Drug Design?

The best quartile for the Current Computer-Aided Drug Design is Q3 (2022).


What's the coverage history of the Current Computer-Aided Drug Design?

The Current Computer-Aided Drug Design coverage history can be summarized as follows: 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 8920 Springer Netherlands 26 2.28
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
Journal of Competition Law and Economics journal 14815 Oxford University Press 29 0.72
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
International Journal of Mathematical Education in Science and Technology journal 10040 Taylor and Francis Ltd. 39 1.33
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Abacus journal 8398 Wiley-Blackwell Publishing Ltd 49 2.52
Educational Measurement: Issues and Practice journal 4494 Wiley-Blackwell Publishing Ltd 59 1.53
Exploration Geophysics journal 16383 Taylor and Francis Ltd. 48 1.17
Genes and Nutrition journal 6154 BioMed Central Ltd. 61 3.28

Check complete list




Year wise Impact Score (IS) of Current Computer-Aided Drug Design

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.73
2021 1.55
2020 1.32
2019 0.77
2018 1.03
2017 0.74
2016 0.79
2015 1.32
2014 1.21



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All